With the development of near-infrared
II (NIR-II) fluorescence
imaging, Ag2Se quantum dots (QDs) have become promising
label candidates due to their negligible toxicity and narrow band
gap. Despite their potential for gastrointestinal (GI) imaging, the
application of Ag2Se QDs still presents significant challenges
due to issues such as fluorescence extinction or poor stability in
the complex digestive microenvironment. Herein, we have proposed a
novel approach to the continuous production of Se precursors using
glutathione (GSH) as the reductant under acidic conditions, realizing
the continuous growth of water-dispersible Ag2Se QDs. The
Ag2Se QDs emitting at 600–1100 nm have been successfully
synthesized. Meanwhile, the silver-rich surface of the synthesized
NIR-II Ag2Se QDs has been passivated well with the dense
GSH, resulting in exceptional colloidal stability and photostability
and endowing them with acid resistance. As a result, the obtained
NIR-II Ag2Se QDs have exhibited remarkable stability in
gastric acid, thus enabling their utilization for long-term real-time
monitoring of GI peristalsis via NIR-II fluorescence imaging. Moreover,
in contrast to conventional barium meal-based X-ray imaging, NIR-II
fluorescence imaging with as-prepared NIR-II Ag2Se QDs
can offer clearer visualization of fine intestinal structures, with
a width as small as 1.07 mm. The developed strategy has offered a
new opportunity for the synthesis of acid-resistant nanocrystals,
and the acid-resistant, low-toxicity, and biocompatible NIR-II Ag2Se QDs synthesized in this work show a great promise for GI
imaging and diagnosis of GI diseases in vivo.